Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma.
Cancer Cell. 2022 Jan 10;40(1):70-87.e15. doi: 10.1016/j.ccell.2021.12.006. Epub 2021 Dec 30.
Cancer Cell. 2022.
PMID: 34971568